PGEN Precigen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGEN

Price (delayed)

$1.665

Market cap

$420.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.39

Enterprise value

$409.51M

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases ...

Highlights
Precigen's debt has plunged by 69% YoY and by 6% from the previous quarter
PGEN's gross margin has plunged by 106% YoY
PGEN's gross profit has dropped by 101% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://precigen.com
Peers: NVCR NVAX

Key stats

What are the main financial stats of PGEN
Market
Shares outstanding
252.42M
Market cap
$420.28M
Enterprise value
$409.51M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.27
Price to sales (P/S)
76.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
75.29
Earnings
Revenue
$5.44M
EBIT
-$97.19M
EBITDA
-$90.64M
Free cash flow
-$68.26M
Per share
EPS
-$0.39
Free cash flow per share
-$0.27
Book value per share
$0.39
Revenue per share
$0.02
TBVPS
$0.28
Balance sheet
Total assets
$134.85M
Total liabilities
$37.83M
Debt
$6.71M
Equity
$97.02M
Working capital
$20.77M
Liquidity
Debt to equity
0.07
Current ratio
1.72
Quick ratio
1.6
Net debt/EBITDA
0.12
Margins
EBITDA margin
-1,666.5%
Gross margin
-4.2%
Net margin
-1,781.7%
Operating margin
-1,851.3%
Efficiency
Return on assets
-56.7%
Return on equity
-73.2%
Return on invested capital
-151.5%
Return on capital employed
-91.6%
Return on sales
-1,787%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGEN stock price

How has the Precigen stock price performed over time
Intraday
0.3%
1 week
4.72%
1 month
7.42%
1 year
31.1%
YTD
24.25%
QTD
5.38%

Financial performance

How have Precigen's revenue and profit performed over time
Revenue
$5.44M
Gross profit
-$228,000
Operating income
-$100.69M
Net income
-$96.91M
Gross margin
-4.2%
Net margin
-1,781.7%
PGEN's gross margin has plunged by 106% YoY
PGEN's gross profit has dropped by 101% year-on-year
Precigen's revenue has plunged by 77% YoY and by 13% from the previous quarter
Precigen's operating income has decreased by 31% YoY

Growth

What is Precigen's growth rate over time

Valuation

What is Precigen stock price valuation
P/E
N/A
P/B
4.27
P/S
76.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
75.29
PGEN's P/B is 58% above its last 4 quarters average of 2.7 but 42% below its 5-year quarterly average of 7.3
PGEN's equity is down by 47% year-on-year and by 18% since the previous quarter
PGEN's P/S is 94% below its 5-year quarterly average of 1312.7 but 65% above its last 4 quarters average of 46.0
Precigen's revenue has plunged by 77% YoY and by 13% from the previous quarter

Efficiency

How efficient is Precigen business performance
The ROIC has contracted by 34% from the previous quarter
PGEN's return on equity is down by 18% since the previous quarter
The ROA has contracted by 17% from the previous quarter
Precigen's return on sales has decreased by 16% QoQ

Dividends

What is PGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGEN.

Financial health

How did Precigen financials performed over time
PGEN's quick ratio is down by 44% YoY and by 43% from the previous quarter
The company's total assets fell by 44% YoY and by 11% QoQ
Precigen's debt is 93% less than its equity
Precigen's debt has plunged by 69% YoY and by 6% from the previous quarter
PGEN's equity is down by 47% year-on-year and by 18% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.